Magee Thomson Investment Partners’s Ambit Biosciences Corp AMBI Stock Holding History

Magee Thomson Investment Partners’s Portfolio AMBI Stock Details AMBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-426	Closed	-$7K	–	182
2014 Q3	$7K	Buy	426 +137	+47%	+$941	﹤0.01%	109
2014 Q2	$2K	Sell	289 -2	-0.7%	-$14	﹤0.01%	150
2014 Q1	$3K	Hold	291	–	–	﹤0.01%	148
2013 Q4	$3K	Buy	+291	New	+$3.89K	﹤0.01%	146

Magee Thomson Investment Partners's AMBI Position: Q4 2014 in Review

Magee Thomson Investment Partners sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 426 shares — an estimated $7K sold.

Magee Thomson Investment Partners first reported a position in AMBI in Q4 2013 and held it in 4 quarters. The position peaked at $7K in Q3 2014. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.

Magee Thomson Investment Partners reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
Magee Thomson Investment Partners sold 426 Ambit Biosciences Corp shares in Q4 2014, an estimated $7K.
Magee Thomson Investment Partners first reported a position in Ambit Biosciences Corp in Q4 2013 and held it in 4 quarters.
Magee Thomson Investment Partners's Ambit Biosciences Corp position peaked at $7K in Q3 2014.
0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.

Based on Magee Thomson Investment Partners's 13F filing for Q4 2014, filed 15 Jan 2015.